Previous Close | 1.0200 |
Open | 0.3700 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 62.50 |
Expire Date | 2024-06-21 |
Day's Range | 0.3700 - 1.0500 |
Contract Range | N/A |
Volume | |
Open Interest | 2.46k |
NORTHAMPTON, MA / ACCESSWIRE / May 28, 2024 / Gilead Sciences: In an effort to advance access to cancer prevention and early detection among U.S. workers, the Biden Cancer Moonshot recently announced a series of actions that organizations are taking ...
FOSTER CITY, Calif., May 22, 2024--Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research to be presented at the European Association for the Study of the Liver (EASL) Congress, June 5-8, 2024 in Milan, Italy. Key findings from more than 25 abstracts will include:
Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.